Research reveals that in osteoporosis, the accumulation of ROS decreases nuclear translocation of the Nrf2 TF, thereby reducing the expression of antioxidant genes, which promotes osteoclastogenesis and aggravates osteoporosis. The gene discussed is TF; the disease is osteoporosis.